FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Bupropion HCl sustained-release (Actavis), finalizing changes to the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence
• Seasonal Affective Disorder

Drugs mentioned

• Bupropion HCl (SR) (Bupropion hydrochloride sustained-release)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)